Kabra Drugs informs about standalone financial results

15 Nov 2016 Evaluate

Kabra Drugs has informed about Standalone Financial Results for the period ended September 30, 2016 and Standalone Limited Review for the period ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

7.19 0.00 (0.00%)
26-Mar-2024 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.